Adherence to home spirometry among patients with IPF: results from the INMARK trial

Imre Noth (1) , Toby M. Maher (2) , Kerri A. Johannson (3) , Nazia Chaudhuri (4) , Stephane Jouneau (5, 6) , Andreas Michael (7) , Klaus B. Rohr (8) , Manuel Quaresma (8) , Susanne Stowasser (8) , Vincent Cottin (9, 10)

1 Virginia Polytechnic Institute and State University [Blacksburg]
2 Imperial College London
3 University of Calgary
4 MFT - Manchester University NHS Foundation Trust
5 Irset - Institut de recherche en santé, environnement et travail
6 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
7 Syneos Health Farnborough
8 Boehringer Ingelheim Pharma GmbH & Co. KG
9 Centre de Référence des Maladies Pulmonaires Rares [Hôpital Louis Pradel - HCL]
10 Université de Lyon

Mots clés: Monitoring; Idiopathic pulmonary fibrosis; Spirometry

Domaines: Sciences du Vivant [q-bio]

Imre Noth, Toby M. Maher, Kerri A. Johannson, Nazia Chaudhuri, Stephane Jouneau, et al.. Adherence to home spirometry among patients with IPF: results from the INMARK trial. European Respiratory Journal, 2019, 54, ⟨10.1183/13993003.congress-2019.PA2241⟩. ⟨hal-02470498⟩